Tuya Pal, MD, discusses the importance of genetic risk assessment shaping management guidelines in ovarian cancer.
Tuya Pal, MD
Advertisement
Articles by Tuya Pal, MD
Advertisement
Latest Updated Articles
Dr. Tuya Pal on Genetic Risk Assessment in Ovarian CancerPublished: April 15th 2016 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
